BioSpace News Archive

GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019

BNCT Cancer Therapy Facility at Edogawa Hospital Receives International Team of Eminent Physicians and Scientists

October 21, 2019
·
2 min read
Policy

Aerpio Pharmaceuticals Announces Review of Strategic Alternatives

Aerpio Pharmaceuticals, Inc. announced that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value from the Company’s clinical assets and cash resources, which amounted to $48.2 million as of June 30, 2019.

October 21, 2019
·
5 min read
Policy

Henry Schein To Be Dismissed From Summit County Opioid Litigation

Company to Make Donation to Establish Pain Management Education Foundation

October 21, 2019
·
6 min read
Theratechnologies Provides Details About R&D Day Webcast

Theratechnologies Inc. (“Theratechnologies” or the “Company”) (NASDAQ: THTX) (TSX: TH), a commercial-stage pharmaceutical company addressing unmet medical needs for people with orphan medical conditions, including those living with HIV, is pleased to provide details about the webcast of its R&D Day.

October 21, 2019
·
1 min read
Business

Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer

Accuray Incorporated (Nasdaq: ARAY) announced today that Suzanne Winter has joined the company as Senior Vice President, Chief Commercial Officer effective October 21, 2019

October 21, 2019
·
4 min read
Genetown

Biogen and Samsung Bioepis to Present Data for Infliximab and Adalimumab Biosimilars at United European Gastroenterology Week

Biogen Inc. (Nasdaq: BIIB) and Samsung Bioepis today announced that they will present new real-world data from the companies’ anti-TNF biosimilar portfolio, which includes FLIXABI™ (infliximab) and IMRALDI™ (adalimumab).

October 21, 2019
·
8 min read
Biotech Bay

TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY® Annual Meeting and in International Journal of Nanomedicine TLC590 showed faster and longer lasting pain relief than ropivacaine

TLC recently presented data at the American Society of Anesthesiologists ANESTHESIOLOGY® annual meeting from a Phase I/II clinical trial which showed TLC590 to yield more immediate and long-lasting pain reduction than ropivacaine.

October 21, 2019
·
5 min read
Business

Turning Point Therapeutics to Host Third Quarter 2019 Conference Call

Turning Point Therapeutics, Inc. will report third quarter financial results following the close of U.S. financial markets on Nov. 4 and host a conference call at 1:30 p.m. PT/4:30 p.m. ET to discuss the results and provide operational updates.

October 21, 2019
·
1 min read
BioForest

Seattle Genetics Announces Positive Topline Results from Pivotal Trial of Tucatinib in Locally Advanced or Metastatic HER2-Positive Breast Cancer

Seattle Genetics, Inc. announced positive topline results from the HER2CLIMB trial, a randomized, double-blind, placebo-controlled, active comparator pivotal trial evaluating tucatinib.

October 21, 2019
·
11 min read
Business

Dr. Mark H. Pollack named Chief Medical Officer for Myriad NeuroscienceHighly Accomplished Psychiatrist to Lead Company Efforts to Make GeneSight® Psychotropic Standard-of-Care in Clinical Practice

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that it has named Mark H. Pollack, M.D., chief medical officer of Myriad Neuroscience effective Jan. 15, 2020.

October 21, 2019
·
6 min read